An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST)
dc.contributor.author | Ahrens, M. | |
dc.contributor.author | Escudier, B. | |
dc.contributor.author | Haanen, J. | |
dc.contributor.author | Boleti, E. | |
dc.contributor.author | Gross-Goupil, M. | |
dc.contributor.author | Grimm, M. O. | |
dc.contributor.author | Negrier, S. | |
dc.contributor.author | Barthelemy, P. | |
dc.contributor.author | Gravis, G. | |
dc.contributor.author | Ivanyi, P. | |
dc.contributor.author | Bedke, J. | |
dc.contributor.author | Castellano, D. | |
dc.contributor.author | Panic, A. | |
dc.contributor.author | Mellado, B. | |
dc.contributor.author | Maroto, P. | |
dc.contributor.author | Rottey, S. | |
dc.contributor.author | Zschabitz, S. | |
dc.contributor.author | Florcken, A. | |
dc.contributor.author | Bogemann, M. | |
dc.contributor.author | Waddell, Thomas | |
dc.contributor.author | Rodriguez, C. S. | |
dc.contributor.author | Lorch, A. | |
dc.contributor.author | Deckbar, D. | |
dc.contributor.author | Hartmann, A. | |
dc.contributor.author | Bergmann, L. | |
dc.date.accessioned | 2023-01-16T14:12:59Z | |
dc.date.available | 2023-01-16T14:12:59Z | |
dc.date.issued | 2022 | en |
dc.identifier.citation | Ahrens M, Escudier B, Haanen J, Boleti E, Gross-Goupil M, Grimm MO, et al. An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST). Oncology Research and Treatment. 2022 Nov;45(SUPPL 3):101-2. PubMed PMID: WOS:000883051700235. | en |
dc.identifier.uri | http://hdl.handle.net/10541/625908 | |
dc.language.iso | en | en |
dc.title | An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | University Hospital Frankfurt, Medical Clinic II, Hematology and Oncology, Frankfurt, Deutschland | en |
dc.identifier.journal | Oncology Research and Treatment | en |
dc.description.note | en] |